Zoetis Debt to Equity Ratio 2011-2018 | ZTS

Current and historical debt to equity ratio values for Zoetis (ZTS) over the last 10 years.
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.000B $5.307B
Zoetis discovers, develops, manufactures and markets veterinary vaccines and medicines, complemented by diagnostic products and genetic tests and supported by a range of services.
Stock Name Country Market Cap PE Ratio
Shire (SHPG) Ireland $52.299B 11.19
Grifols (GRFS) Spain $14.653B 18.99
Jazz Pharmaceuticals (JAZZ) Ireland $10.539B 17.73
Neurocrine Biosciences (NBIX) United States $9.110B 0.00
Nektar Therapeutics (NKTR) United States $8.191B 0.00
Sage Therapeutics (SAGE) United States $7.835B 0.00
Catalent (CTLT) United States $5.716B 26.62
Ionis Pharmaceuticals (IONS) United States $5.557B 0.00
United Therapeutics (UTHR) United States $5.323B 9.66
FibroGen (FGEN) United States $5.266B 0.00
Loxo Oncology (LOXO) United States $5.263B 0.00
Taro Pharmaceutical Industries (TARO) Israel $4.522B 18.53
Madrigal Pharmaceuticals (MDGL) United States $4.104B 0.00
Ironwood Pharmaceuticals (IRWD) United States $3.163B 0.00
Aerie Pharmaceuticals (AERI) United States $2.883B 0.00
Heron Therapeutics (HRTX) United States $2.788B 0.00
Portola Pharmaceuticals (PTLA) United States $2.651B 0.00
USANA Health Sciences (USNA) United States $2.623B 25.23
Spectrum Pharmaceuticals (SPPI) United States $2.397B 0.00
Endo (ENDP) Ireland $2.363B 3.22
Enanta Pharmaceuticals (ENTA) United States $2.332B 43.07
Xencor (XNCR) United States $2.253B 0.00
TESARO (TSRO) United States $2.223B 0.00
Zogenix (ZGNX) United States $2.147B 0.00
PTC Therapeutics (PTCT) United States $1.676B 0.00
Corcept Therapeutics (CORT) United States $1.628B 27.17
Pacira Pharmaceuticals (PCRX) United States $1.493B 0.00
TherapeuticsMD (TXMD) United States $1.425B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.414B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $1.384B 0.00
Impax Laboratories (AMRX) United States $1.369B 29.41
ImmunoGen (IMGN) United States $1.329B 0.00
Radius Health (RDUS) United States $1.306B 0.00
TRICIDA INC (TCDA) United States $1.167B 0.00
Endocyte (ECYT) United States $1.147B 0.00
Esperion Therapeutics (ESPR) United States $1.129B 0.00
OptiNose (OPTN) United States $1.022B 0.00
Flexion Therapeutics (FLXN) United States $1.015B 0.00
Karyopharm Therapeutics (KPTI) United States $0.914B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.794B 0.00
GlycoMimetics (GLYC) United States $0.675B 0.00
CASI Pharmaceuticals (CASI) United States $0.645B 0.00
Collegium Pharmaceutical (COLL) United States $0.641B 0.00
Dova Pharmaceuticals (DOVA) United States $0.641B 0.00
Odonate Therapeutics (ODT) United States $0.639B 0.00
Aclaris Therapeutics (ACRS) United States $0.634B 0.00
ChemoCentryx (CCXI) United States $0.625B 43.83
BioCryst Pharmaceuticals (BCRX) United States $0.613B 0.00
TRANSLATE BIO (TBIO) United States $0.582B 0.00
Akebia Therapeutics (AKBA) United States $0.572B 0.00
Siga Technologies (SIGA) United States $0.568B 0.00
Depomed (DEPO) United States $0.520B 0.00
ArQule (ARQL) United States $0.505B 0.00
Majesco Entertainment (COOL) United States $0.492B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.483B 0.00
Lannett Co Inc (LCI) United States $0.477B 4.39
Synergy Pharmaceuticals (SGYP) United States $0.466B 0.00
FORTY SEVEN INC (FTSV) United States $0.460B 0.00
VERRICA PHARMA (VRCA) United States $0.460B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.453B 0.00
Dermira (DERM) United States $0.449B 0.00
Concert Pharmaceuticals (CNCE) United States $0.391B 0.00
Mast Therapeutics (SVRA) United States $0.381B 0.00
XERIS PHARMA (XERS) United States $0.363B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.342B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.336B 26.24
Catalyst Pharmaceuticals (CPRX) United States $0.331B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.319B 0.00
Minerva Neurosciences (NERV) United States $0.318B 0.00
Achaogen (AKAO) United States $0.316B 0.00
NEON THERAPEUTC (NTGN) United States $0.312B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.301B 0.00
Tyme Technologies (TYME) United States $0.292B 0.00
Zafgen (ZFGN) United States $0.277B 0.00
Jounce Therapeutics (JNCE) United States $0.254B 0.00
DURECT (DRRX) United States $0.254B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.252B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.244B 0.00
Redhill Biopharma (RDHL) Israel $0.241B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.239B 0.00
Ocular Therapeutix (OCUL) United States $0.231B 0.00
CTI BioPharma (CTIC) United States $0.231B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.230B 0.00
Galectin Therapeutics (GALT) United States $0.228B 0.00
Ardelyx (ARDX) United States $0.215B 0.00
Zomedica Pharmaceuticals (ZOM) United States $0.214B 0.00
Aratana Therapeutics (PETX) United States $0.210B 0.00
Immune Design (IMDZ) United States $0.209B 0.00
ProNAi Therapeutics (SRRA) Canada $0.205B 0.00
Ampio Pharmaceuticals (AMPE) United States $0.202B 0.00
IMV INC (IMV) Canada $0.201B 0.00
ContraFect (CFRX) United States $0.191B 0.00
Melinta Therapeutics (MLNT) United States $0.190B 0.00
Neos Therapeutics (NEOS) United States $0.187B 0.00
Adherex Technologies (FENC) United States $0.174B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.172B 0.00
Nature's Sunshine Products (NATR) United States $0.172B 0.00
MediWound (MDWD) Israel $0.170B 0.00
Opexa Therapeutics (ACER) United States $0.169B 0.00
Calithera Biosciences (CALA) United States $0.168B 0.00
Aldeyra Therapeutics (ALDX) United States $0.160B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.159B 0.00
MEI Pharma (MEIP) United States $0.156B 0.00
Molecular Templates (MTEM) United States $0.135B 0.00
Cardiome Pharma (CORV) Canada $0.134B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.132B 0.00
Forward Pharma (FWP) Denmark $0.131B 0.00
Juniper Pharmaceuticals (JNP) United States $0.127B 190.00
SteadyMed (STDY) Israel $0.120B 0.00
Iterum Therapeutics (ITRM) Ireland $0.119B 0.00
Infinity Pharmaceuticals (INFI) United States $0.114B 0.00
Nivalis Therapeutics (ALPN) United States $0.113B 0.00
Otonomy (OTIC) United States $0.110B 0.00
Recro Pharma (REPH) United States $0.110B 0.00
Affimed (AFMD) Germany $0.109B 0.00
Rafael Holdings (RFL) United States $0.107B 0.00
BioLineRx (BLRX) Israel $0.098B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.097B 0.00
KalVista Pharmaceuticals (KALV) United States $0.093B 0.00
Actinium Pharmaceuticals (ATNM) United States $0.087B 0.00
SCYNEXIS (SCYX) United States $0.086B 0.00
KemPharm (KMPH) United States $0.078B 0.00
Natural Alternatives (NAII) United States $0.076B 9.81
Novan (NOVN) United States $0.076B 0.00
Trillium Therapeutics (TRIL) Canada $0.074B 0.00
Genocea Biosciences (GNCA) United States $0.067B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.066B 0.00
Champions Oncology (CSBR) United States $0.064B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.062B 0.00
Capnia (SLNO) United States $0.056B 0.00
Mannatechorporated (MTEX) United States $0.056B 13.65
Heat Biologics (HTBX) United States $0.048B 0.00
Avenue Therapeutics (ATXI) United States $0.043B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.041B 37.48
NovaBay Pharmaceuticals (NBY) United States $0.040B 0.00
Xenetic Biosciences (XBIO) United States $0.036B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.036B 0.00
Biomerica (BMRA) United States $0.035B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.035B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.034B 0.00
Onconova Therapeutics (ONTX) United States $0.034B 0.00
HANCOCK JAFFE (HJLI) United States $0.034B 0.00
ProPhase Labs (PRPH) United States $0.034B 3.82
IsoRay (ISR) United States $0.033B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.032B 0.00
Shineco (TYHT) China $0.030B 2.58
Lipocine (LPCN) United States $0.030B 0.00
Regulus Therapeutics (RGLS) United States $0.030B 0.00
NanoViricides (NNVC) United States $0.029B 0.00
Citius Pharmaceuticals (CTXR) United States $0.028B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.025B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.025B 0.00
Can-Fite Biopharma (CANF) Israel $0.024B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.023B 0.00
Cyanotech (CYAN) United States $0.023B 21.94
Aradigm (ARDM) United States $0.023B 0.00
ESSA Pharma (EPIX) Canada $0.022B 0.00
Aviragen Therapeutics (VXRT) United States $0.022B 0.00
Midatech Pharma (MTP) United Kingdom $0.021B 0.00
Intellipharmaceutics (IPCI) Canada $0.020B 0.00
Egalet (EGLT) United States $0.020B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.019B 0.00
Aralez Pharmaceuticals (ARLZ) Canada $0.019B 0.00
Bio-Path Holdings (BPTH) United States $0.018B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.016B 0.00
Pain Therapeutics (PTIE) United States $0.016B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.015B 0.00
India Globalization Capital (IGC) United States $0.014B 0.00
Skyline Medical (AIPT) United States $0.014B 0.00
Jaguar Animal Health (JAGX) United States $0.014B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.012B 0.00
PharmAthene (ALT) United States $0.012B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.012B 0.00
OncoGenex Pharmaceuticals (ACHV) United States $0.010B 0.00
Apricus Biosciences (APRI) United States $0.009B 0.00
RXi Pharmaceuticals (RXII) United States $0.008B 0.00
Biostar Pharmaceuticals (BSPM) China $0.006B 3.36
Bio Blast Pharma (ORPN) Israel $0.005B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.002B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
ELECTROCORE LLC (ECOR) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00